top of page
Regulatory news and experts insights.
Stay updated with the latest developments, guidance, and resources in chemical regulations.
Search


The European Positive Lists (EUPL) at the Core of Directive (EU) 2020/2184
La Directive (UE) 2020/2184 établit un cadre harmonisé destiné à garantir la sécurité des matériaux et des produits entrant en contact avec l’eau destinée à la consommation humaine. Pour atteindre cet objectif, elle introduit un dispositif central : les Listes Positives Européennes (EUropean Positive Lists, EUPL).
Dec 34 min read


REACH Authorisation: Process, Requirements and Key Insights
The REACH Regulation (EC No 1907/2006) aims to ensure a high level of protection for human health and the environment from the risks posed by chemical substances. Among its four main pillars, Registration, Evaluation, Authorisation and Restriction, the Authorisation process is often the most complex for non-specialists to understand. Yet it plays a critical role in managing the most hazardous substances on the European market.
Nov 264 min read


Directive (EU) 2020/2184: Revision of Drinking Water Quality Standards in EU
The Directive (EU) 2020/2184, adopted on December 16, 2020, marks a pivotal change in the management of drinking water across EU. It replaces the 1998 directive and aims to ensure universal access to safe and high-quality drinking water while enhancing transparency, monitoring, and risk management. This legislation has significant implications for water suppliers, industries dealing with materials in contact with water, as well as consultants and other stakeholders in the sec
Nov 196 min read


Proposed European Restriction on Octocrylene (CAS 6197-30-4): Scientific and Regulatory Issues
Octocrylene is a widely used ultraviolet (UV) filter in cosmetic products, particularly sunscreens, designed to absorb UVB and part of the UVA spectrum, thereby protecting the skin against the harmful effects of sunlight. Currently, octocrylene is authorised in cosmetic products at a maximum concentration of 9% in accordance with Annex VI of the European Cosmetics Regulation...
Nov 124 min read


The Era of N-Nitrosamines in the Pharmaceutical Industry – A Comprehensive Toxicological Perspective
L'apparition inattendue d'impuretés de N-nitrosamines dans les médicaments a marqué un tournant réglementaire majeur. Ces composés, connus dans l'environnement et l'alimentation, ont forcé l'industrie pharmaceutique mondiale à revoir ses processus. Face à cette situation, une coordination internationale sans précédent a vu le jour entre les agences réglementaires mondiales, telles que la FDA (États-Unis),
Nov 54 min read
bottom of page
